Time to treatment benefit for adult patients with Fabry disease receiving agalsidase β: data from the Fabry RegistryAlberto Ortíz, David G. Warnock, Joel Charrow et al.|Journal of Medical Genetics|2016Cited by 147
Use of a rare disease registry for establishing phenotypic classification of previously unassigned <i>GLA</i> variants: a consensus classification system by a multispecialty Fabry disease genotype–phenotype workgroupDominique P. Germain, David G. Warnock, João Paulo Oliveira et al.|Journal of Medical Genetics|2020Cited by 66